Clinical Trials in Arizona

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

State

All 19 states

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

US states

Start

Recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)

NCT07282847Pompe Disease (Late-onset), Pompe Disease Late-Onset, LOPD

AskBio Inc

Phase 1/2

Arizona, California, New York, North Carolina, Pennsylvania, Texas, Virginia

2026-04-15

Active, closed

A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)

NCT04093349Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2, Glycogen Storage Disease Type II

Spark Therapeutics, Inc.

Phase 1/2

Arizona, California, Georgia, Kansas, Minnesota, Oregon, Pennsylvania, Utah

2020-10-01

Recruiting

Pompe Pregnancy Sub-Registry

NCT00567073Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset), Glycogenesis 2 Acid Maltase Deficiency

Genzyme, a Sanofi Company

Observational

Arizona, Florida, Georgia, Indiana, Iowa, Michigan, Missouri, New York

2007-06-18

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 September 2026. https://priyalifescience.com/clinical-trials-usa/state/arizona

Query this register directly

GET /api/trials?country=usa&status=recruiting&format=json Try it now →